BACKGROUND: Second-generation and third-generation oral contraceptives containing 30 mcg or more of ethinylestradiol (EE) decrease insulin sensitivity (SI). In this study, we investigated whether SI is decreased by contraceptives containing lower doses EE or by progestins with antiandrogenic properties. STUDY DESIGN: Twenty-eight young healthy...
-
2009 (v1)PublicationUploaded on: April 14, 2023
-
2013 (v1)Publication
BACKGROUND: Hypertension is recognized as a major risk factor for coronary, cerebral and renal vascular disease. Hormonal methods of contraception may increase the risk for cardiovascular events. We evaluated whether the combined hormonal contraceptive vaginal ring that releases 15-mcg ethinylestradiol and 120 mcg of etonogestrel each day...
Uploaded on: April 14, 2023 -
2007 (v1)Publication
OBJECTIVE: To evaluate modification in body weight and anthropometric indexes in women at the time of menopause. DESIGN: Prospective longitudinal study. SETTING: Menopause Center at the University Hospital of Modena. PATIENT(S): Women in perimenopause (n = 87), ovariectomized (n = 60), and in postmenopause (n = 182) without and with treatment....
Uploaded on: April 14, 2023 -
2011 (v1)Publication
Vasomotor symptoms may increase the risk for cardiovascular diseases through still elusive mechanisms. Increased cortisol release may favor atherosclerosis. In this study, we tested whether vasomotor and psychological symptoms are associated with an increase in cortisol levels.A cross-sectional investigation on women in early menopause enrolled...
Uploaded on: April 14, 2023 -
2012 (v1)Publication
Objectives Conflicting evidence indicates an increased risk for cardiovascular disease in postmenopausal women suffering from hot flushes. In this study, we tested whether, beyond hot flushes, menopausal symptoms are associated with biochemical and biophysical risk factors for cardiovascular disease. Methods Retrospective cross-sectional...
Uploaded on: March 27, 2023